:true:
The Power of Precision
false
us
ZenoTOF 7600 system
X500R system
X500B system
View all
SelexION device
SCIEX 7500 system
SCIEX Triple Quad 6500+ system
SCIEX 5500+ system
QTRAP 6500+ system
QTRAP 4500 system
Citrine system
4500MD system
Jasper system
View all mass spectrometers
Echo MS system
Biologics Quant solution
Biotransform solution
MPX 2.0 High Throughput Multiplexing system
OptiFlow Quant solution
View all integrated solutions
BioPhase 8800 system
CESI 8000 Plus system
PA 800 Plus system
P/ACE MDQ Plus system
GenomeLab GeXP system
View all capillary electrophoresis
Advance your research with front-end instruments designed to help you realize the full power of your mass spectrometer. SCIEX has the broadest portfolio of ESI-MS front-ends that can facilitate various flow rates, sample requirements and sensitivities. No one else offers the entire range of analytical flow, microflow, nanoflow LC-MS and even ultra-low flow CESI-MS.
ExionLC 2.0 series
Micro HPLC columns
M5 MicroLC system
View All
Ultra-low Flow CESI-MS
View all front-end HPLC MS
Differential mobility spectrometry (DMS) and ion mobility spectrometry are analytical techniques used to separate ions based on their gas phase mobility. Multiple types of ion mobility devices exist, such as drift tubes, traveling wave, and high-field asymmetric waveform devices. Learn how you can separate yourself with Differential Ion Mobility.
The latest ion sources from SCIEX enable enhanced sensitivity and robustness with greater desolvation range across all MS platforms, from Triple Quad to QTRAP and QTOF.
Turbo V ion source
OptiFlow Turbo V ion source
OptiFlow Interface
View all ion sources
vMethod applications are pre-configured and verified LC-MS/MS methods that reduce the need for method development – significantly cutting the time, effort and money to deploy a new assay. Every vMethod provides method conditions, recommended sample prep, LC and MS conditions, and details for applicable MS/MS library databases for key applications.
AA45/20 1.0
aTRAQ
Illicit drugs
Acrylamide
Allergens
Antiobiotics/veterinary drugs
Cannabinoids
Illegal dyes
Melamine
Mycotoxins
Pesticides
Industrial chemicals (bisphenol)
Industrial chemicals (ethanolamines)
Pesticides (herbicides)
Pesticides (Polar)
Pharmaceutical and personal care products (PPCPs)
Peptide and protein bioanalysis
Routine biologics characterization
Benzodiazepines
Blood screening
Drugs of abuse
Etg and ets
Nicotine
THC-COOH
Urine screening
Explore vMethod applications
Software navigator tool
Software downloads
Software activation
Software support policy
Software support plans
Software feature request portal
Software partners
Analyst software
Analyst TF software
SCIEX OS software
Biologics Explorer software
Cliquid software
DiscoveryQuant software
Molecule Profiler software
OneOmics suite
View all software
High resolution and QTRAP libraries can dramatically enhance the quality of your analysis, giving you much improved confidence in your data. With a comprehensive library at your fingertips, you can easily create methods and process targeted and non-targeted screening data on your complex samples, faster and easier than ever before.
All in one library
SCIEX all-in-one HR-MS/MS library with NIST 2017
Antiobiotic Llbrary
Flurochemical library
Forensic library
Mycotoxin library
Natural products
Pesticide library
Wiley Libraries
Antibiotic library
Meta library
Explore the library selector tool
Boost the performance of your mass spectrometer and improve sensitivity, productivity, and data precision. iChemistry Solutions are the world's only reagents and consumables that are custom designed with your success in mind.
RNA 9000 Purity & Integrity kit
aTRAQ kit for amino acid analysis of hydrolysates
aTRAQ kit for amino acid analysis of physiological fluids
Automated protein digestion solution
Protein CE-SDS Purity Analysis kit
Chemical standard kits
CYP450 protein assay - human induction kit
CZE rapid charge variant analysis kit
BioPhase Fast Glycan Labeling and Analysis kit
iDQuant standards kit for pesticide analysis
Lipidyzer platform kits
roQ auEChERS extraction and dispersive kit
Ampliflex diene reagent
Ampliflex keto reagent
Cleavable ICAT reagent
iTRAQ reagent
mTRAQ reagent
View all consumables
QTOF – Quadrupole Time of Flight
QTRAP® – Triple Quad Linear Ion Trap
SWATH® – Data Independent Acquisition
SelexION® – Differential Mobility Separation
MicroLC – Microflow Chromatography
Ultra Low-Flow CESI-MS Technology
iCIEF-MS Technology
Nominal Mass LC-MS-MS
Acoustic Ejection Mass Spectrometry
View All Technology
From substantiating new discoveries through to end-to-end validated workflows for high-throughput biomarker testing in the clinic, thousands of scientists worldwide depend upon mass spec innovation from SCIEX to advance their work in the fields of clinical, research, omics and diagnostics.
Clinical research (coming soon!)
Clinical diagnostics (coming soon!)
View All Clinical
PFAS
Pesticides & herbicides
PPCP
Disinfection by-products
Soil and biota
Ethanolamine
Synthetic polymers
Exposome
Suspect screening
Nanomaterials
View All Environmental Testing
How do you protect your reputation and meet today’s global food safety standards? Whether you are a commercial lab or a food manufacturer, the quality of your food testing data is vital to your business. SCIEX solutions help you meet maximum residue limits (MRLs) with high-quality data that you can genuinely count upon. With a portfolio of applications, your lab can quickly and easily react to diverse market needs.
Pesticide Testing
Mycotoxins Testing
Antibiotics Testing
Potency Testing
Mycotoxin Testing
Terpenes Profiling
Meat Speciation Testing
Food Fraud Analysis
Food Adulterant Testing
Food Dye Testing
Food Omics
Allergen Testing
Ingredient Authenticity & Profiling Analysis
Packaging & Food Contact Substance Analysis
View All Food and Beverage Testing
How do you ensure the integrity of your results in an industry that is never constant? By accurately detecting even the smallest compound angles you can deliver evidence that stands. SCIEX forensic analysis solutions deliver fast, highly accurate data across a multitude of compounds and biomarkers, from the known to the new and novel.
Forensic toxicology (coming soon!)
Homeland security (coming soon!)
Cannabis and hemp potency testing
Doping control (coming soon!)
View All Forensic Testing
Discovery Proteomics
Next-Generation Proteomics
Targeted Proteomics
Discovery Lipidomics
Targeted Lipidomics
Untargeted Metabolomics
Targeted Metabolomics
Metabolic Flux Analysis
Gene Expression Analysis
DNA Sequencing
Genotyping and SNP Analysis
STR Analysis
AFLPs
View All Life Science Research
Transform the capacity and capability of your biologics pipeline with complete end-to-end solutions that make your lab more productive, and more successful. With a longstanding track record in pharma discovery, development and manufacturing, our unparalleled application knowledge with best-in-class hardware, software and support all integrate to revolutionize your lab.
Small Molecule Quant
Peptide Protein Quant
Oligonucleotide Quant
Comprehensive Metabolite Identification
Biotherapeutic Catabolism
Native Mode Analysis
High Throughput ADME
Intact Protein Analysis
Peptide Mapping
Protein Glycosylation/Microhetrogeneity
Purity/Heterogeneity Analysis
Identity/Charge Heterogeneity
Host Cell Proteins
Capsid Analysis
Nucleic Acid and Plasmid Analysis
SNP Analysis
Gene Expression Profiling
View All Pharma and Biopharma
Citrine Mass Spec
4500MD Mass Spec
Jasper HPLC System
Analyst MD Software
Cliquid MD Software
MultiQuant MD Software
ChemoView MD software
Clinical Mass Spec Operators
Clinical Method Developers
Clinical Lab Managers
The SCIEX Now Learning Hub offers the most diverse and flexible learning options available, with best-inclass content that helps you to get the most out of your instrument and take your lab to the next level. Available personalized learning paths based on the latest memory science ensure better knowledge retention, and automated onboarding and enrollment means you’ll get up and running faster.
SCIEX Now Learning Hub offers the most diverse and flexible learning options available, with best-in-class content that helps you to get the most out of your instrument and take your lab to the next level. Available personalized learning paths based on the latest memory science ensure better knowledge retention, and automated onboarding and enrollment means you’ll get up and running faster.
SCIEX Learning Manager provides you with the infrastructure to assign, monitor and report on your staff's competency through a single digital platform. Effectively manage the training process for new hires, ensure continuous staff development and access information with a single log-in to your SCIEX account.
You can browse, filter, or search our extensive list of training offerings. Choose from over 100 self-paced eLearnings or search for an instructor-led course near you. Once you select the course you want to take, you will be directed to Learning Hub for enrollment (login required).
SCIEX Now Online is the Everything, Anytime destination for all your SCIEX support needs. You can keep track of activities that matter most to you and manage your lab in the most efficient way possible. Extensive self-help resources like our deep Knowledge Base, enable you to solve many problems on your own. SCIEX Now is available 24/7 and your new SCIEX instruments are automatically added to your profile when you purchase.
Support Cases
SCIEX Now Learning Hub
Instruments
Manage My Instruments
Registered Software
Activate Software
Resource Library
My Notifications
Request Support
Course Catalog
Software Downloads
SCIEX Store
SCIEX Now New Feature Request
Software New Feature Request
Online ordering solutions
Log In
Don't have an account? Create One
Visit your SCIEX Now™ Dashboard
No one understands your needs and can support your systems better than we can. Our mission is to help you be successful, whether it's to repair your instrument, assist with your workflows, or help you maximize productivity in your lab. Whatever your challenge, global SCIEX Service and Support personnel are subject matter experts who are focused on mass spec and capillary electrophoresis, so you'll be able to achieve your scientific goals quickly and efficiently.
LC-MS Service Plans
Protect Plus Suite for Your New LC-MS
CE Service Plans
Clinical Service Plan
StatusScope Remote Monitoring
Laboratory Optimization Services
Compliance Consultancy
Qualification and Validation
On-Site Applications Support
Professional Relocation Services
View All Instrument Service & Support
Software Accelerator Program
Software Support Plans
Software Support Policy
Premium Access Content
View All Support Tools
SCIEX Now Learning Hub is much more than online courses. For the most comprehensive option, you can select Success Programs: personalized, blended online and in-person courses. If your needs are met by a visit from one of our training experts, you can choose multiple Onsite Training days to get your lab running. Visit a SCIEX training center in North America, Europe or Asia for intensive classroom and laboratory training. And your online courses are available any time, from anywhere, right here.
Login to SCIEX Now Learning Hub
Success Programs at Your Site
Online Course Catalog
Clinical Knowledge Center
Application Scientist Training at Your Site
China
Europe
German CE Courses
India
Japan
Korea
North America
UK
Visit all Training
If you have CE, LC or mass spec questions, then SCIEX has the answers. SCIEX support is the single destination for your system questions. We aim to fully assist you with virtually every application of our instruments, helping you to get the most out of your lab resources and assets.
Frequently Asked Questions
View All Request Support
As a life science researcher, you need the tools and support to help you create the scientific foundation in pursuit of expanding the knowledge-base, whether it is understanding fundamental biology, finding new biomarkers, discovering ways to improve our quality of life, or other areas of research. We are committed to the same goals and put the very same dedication into our work to help you address your most significant research challenges.
Academic Partnership Program
Academic Partners
View All Partnership Programs
Regulatory compliance is as paramount for us as it is for you. That’s why we have made it easy for you to freely reference all relevant technical and product regulatory documents. To give you confidence that, with SCIEX, you will fully comply with legislation, adhere to your laboratory protocol and meet industry standards.
Declaration of Conformance
Safety Data Sheets
Certificates of Analysis
View All Regulatory Documents
SCIEX supplies extensive documentation to help you prepare for, use, and maintain your SCIEX hardware and software products, and we update this documentation regularly. On the Customer Documents page, you can search for and download the latest documents for your product.
Customer Documents
Join the SCIEX community today to interact with your peers, share and exchange ideas, develop your knowledge, stay up-to-date with the latest products, post insights and questions, comment on others and receive support. This community is designed to help you, our customers, move science forward and get the answers you need. We’re committed to engaging with and listening to you, to create the best customer experience possible and to contribute to the success of your work.
Biopharma
Clinical
Environmental / Industrial
Food and Beverage
Forensics
Life Science Research
Pharma
Technology
Knowledge Base Articles
SCIEX Now Feature Requests
Software Feature Requests
Newsletter Archive
Featured Content
FAQs
View All Community
About SCIEX
About Danaher
Customer Profiles
Our History
Our favorite papers
Meet our executives
Career opportunities
Contact us
Press releases
In the news
Awards
You've got questions. We've got experts who can help. Contact us to find out more, talk to a specialist, explore our solutions or get expert support.
Talk to a specialist
Request more information
Request a quote
Request support
SCIEX success network
Frequently asked questions
SCIEX community
Request hosted catalog
Request punchout
Global public relations
508-782-9484
Country/Region Canada Mexico United States
Country/Region Argentina Brazil Chile Colombia Costa Rica Ecuador El Salvador Guatemala Peru Uruguay Venezuela
Country/Region Germany Albania Austria Belgium Bosnia and Herzegovina Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Ireland Italy Latvia Lithuania Luxembourg Macedonia Montenegro Netherlands Norway Poland Portugal Romania Serbia Slovakia Slovenia Spain Sweden Switzerland United Kingdom
Country/Region Bangladesh Brunei Darussalam Cambodia 中国 Hong Kong India Indonesia 日本 한국 Singapore Sri Lanka Taiwan Thailand Viet Nam
Country/Region Bahrain Iran Iraq Israel Jordan Kuwait Lebanon Oman Pakistan Palestine Qatar Saudi Arabia Syria Turkey United Arab Emirates Yemen
Country/Region Algeria Angola Botswana Burundi Egypt Ethiopia Kenya Liberia Libya Morocco Rwanda South Africa Tunisia Uganda United Republic of Tanzania Zambia Zimbabwe
Country/Region Armenia Azerbaijan Belarus Georgia Kazakhstan Kyrgyzstan Moldova Russia Tajikistan Turkmenistan Ukraine Uzbekistan
Country/Region Australia Micronesia New Zealand
AB Sciex is doing business as SCIEX. © 2010-2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB SCIEX™ is being used under license. Beckman Coulter® is being used under license. Product(s) may not be available in all countries. For information on availability, please contact your local representative. For research use only. Not for use in diagnostic procedures.
Download Tech Note (PDF)
Featuring the ZenoTOF 7600 system
Zhichang Yang1 , Paul Baker1 , Sahana Mollah1 , Robert Proos1 and Jonathan Le Huray2 1SCIEX, USA; 2Acuitas Therapeutics Inc
In this technical note, [(4-hydroxybutyl)azanediyl]di(hexane-6,1- diyl) bis(2-hexyldecanoate), commonly known as ALC-0315, and its impurities at relative abundances as low as 0.19% were structurally characterized using EAD fragmentation on the ZenoTOF 7600 system. Collision-induced dissociation (CID) did not generate sufficient fragments to fully characterize ALC-0315 and impurities. In contrast, EAD provided abundant diagnostic fragments to allow near-complete structural elucidation of singly charged compounds (Figure 1).
The use of lipid nanoparticles (LNP) as drug delivery devices has dramatically increased since the advent of the COVID-19 vaccine and introduction of recent gene therapy therapeutics. Lipid impurities in the LNP can attenuate the effectiveness of the active pharmaceutical ingredient (API). For example, N-oxidation of ionizable lipids might lead to covalent modification of ribonucleotides and a loss of mRNA potency. 1 It is therefore necessary to ensure detailed and sensitive characterization of the ionizable lipid and its related impurities. However, detailed characterization of LNPs is challenging using current liquid chromatography-mass spectrometry (LC-MS) methodologies. EAD can be used to provide structurally diagnostic fragment ions to elucidate the distinctive structures of complex lipids. 2-8
Here, the applicability of EAD for the detailed characterization of ALC-0315 and its impurities was tested. This lipid plays a crucial role in the function of LNPs by stabilizing the negatively charged mRNA and its impurities might affect the therapeutic effectiveness of the LNP formulation. 8 Using the ZenoTOF 7600 system equipped with EAD, ALC-0315 and its raw materialrelated impurities were fully characterized. The nature and site of chemical alterations in ALC-0315 resulting from forced degradation were also elucidated using structurally diagnostic fragment ions produced by EAD.
Figure 1. MS/MS spectra acquired for ALC-0315 (m/z = 766.7) using EAD (left) and CID (right). Blue peaks were assigned to a fragment of the structure. Red peaks were not assigned. More than 70% of the EAD-generated peaks were assigned to fragments. EAD generated many more assigned fragments than CID, including an important fragment from the head group of the molecule (m/z = 172) that was used for structural elucidation.
Chemicals and materials: ALC-0315 was provided by Acuitas Therapeutics Inc. Methanol (MeOH) was purchased from LiChrosolv (PN: 1.06035.2500). Ammonium acetate was from Fluka Analytical (PN: 73594-25G). Acetonitrile was (ACN) from Sigma-Aldrich (PN: 34851-4L).
Sample preparation: ALC-0315 standard suspended in PBS with 300mM sucrose was aliquoted 5 mg per vial and subjected to 60°C incubation for 3 days or 5 days for forced degradation.
The intact and degraded ALC-0315 stock solutions were diluted 100-fold with a solution of 60:40 (v/v), ACN/MeOH with 10 mM ammonium acetate (mobile phase B). The resulting solution was further diluted 100-fold with a solution containing 15% water, 30% MeOH and 55% ACN with 10mM ammonium acetate (mobile phase A). The solution was then analyzed directly by
LCMS/MS. LC-MS/MS analysis: Samples were analyzed by a LC-MS/MS system equipped with a Waters H-class UPLC and a SCIEX ZenoTOF 7600 system. The samples were separated using a UHPLC Peptide BEH C18 column (2.1 × 150 mm, 1.7 μm, 130 Å, Waters, PN: 186003687) using the gradient conditions shown in Table 1. The flow rate was set to 0.3 mL/min and the column temperature was set to 70°C. The injection volume was set to 2 µL.
Table 1. LC gradient.
LC-MS/MS data were acquired using a data-dependent acquisition (DDA) scan mode. The parameters used in these experiments are shown in Tables 2 and 3.
Table 2. TOF MS parameters.
Table 3. TOF MS/MS parameters.
Data processing: Structural elucidation was performed and relative quantification was determined using the Explorer module of SCIEX OS software.
Figure 2. TIC of ALC-0315 exposed to forced degradation. The structure of ALC-0315 is shown in the yellow inset square. Forced degradation of ALC-0315 was achieved by incubating the compound at 60°C for 3 or 5 days. The m/z values for 4 impurities are shown above the TIC. These degradation products included the loss of an acyl chain (m/z = 428.4087), the loss of the head group (m/z = 694.6690), oxidation (m/z = 782.7216) and the loss of an alkyl chain (m/z = 708.6495).
Forced degradation experiments were performed to expedite the formation of impurities. Impurities might be formed during the LNP formulation process because it involves heat and mechanical stress. Therefore, it is important to identify and report any impurities that are formed.
Figure 2 shows the total ion chromatogram (TIC) for the differentially treated samples. The intensities of impurities, represented by the smaller peaks in the TIC, appeared or increased during the incubation period. The m/z of each impurity and ALC-0315 is shown above the TIC. Based on the formula finder module in SCIEX OS software, the peak at m/z 428.4087 likely corresponds to a loss of the acyl chain from the intact ALC0315. Similarly, the peak at m/z 694.6690 likely corresponds to the loss of the head group, the peak at m/z 782.7216 likely corresponds to the addition of O and the peak at m/z 708.6495 likely corresponds to the loss of an alkyl chain (C4H9) and desaturation.To confirm the structure of these impurities, MS/MS interpretation is necessary.
The 5-day incubation time was expected to provide the greatest distribution of ALC-0315 impurities and therefore the data from this sample were analyzed in detail. Figure 3 shows the extracted ion chromatogram (XIC) of ALC-0315 and several lowabundant impurities. ALC-0315 eluted at 12.06 min. The impurity peaks were observed at intensities ranging from 5.9% to 0.2% relative to ALC-0315. These results demonstrate the wide interscan dynamic range of the ZenoTOF 7600 system for lipid impurity analysis. Table 4 summarizes the various impurities identified and their intensities relative to the ALC-0315 peak based on the TOF MS peak area.
Table 4. Compounds identified by EAD in ALC-0315-5D
Figure 3. XIC of intact ALC-0315 and 6 low-abundant impurities after 5 days of forced degradation. The top panel shows the normalized XIC of all compounds, in which ALC-0315 (peak 1) is the base peak of the chromatogram. The bottom panel shows the same chromatogram with a 10x zoom of the y-axis to better visualize the low-abundant impurities (peaks 2-7). Impurities were identified at relative intensities as low as 0.2%.
MS/MS data enabled the detailed structural elucidation of ALC0315 and impurities. Structural information for peaks 1, 2 and 7 (Figure 3) is presented here. The characterization of peaks 3, 4, 5 and 6 is included in the supplemental information.
The m/z observed by TOF MS for the singly charged ALC-0315 precursor ion (Figure 3, peak 1) matched the theoretical m/z of ALC-0315 within 2 ppm (Table 4). This ion was selected for fragmentation by EAD (Figure 1, left) or CID (Figure 1, right). EAD provided a more information-rich spectrum than CID. More than 100 peaks were assigned to structures from the in silicoderived fragment library with <0.01 Da mass error. In contrast, CID generated approximately 10 fragment ions. The relatively high signal of the peak at m/z 528.5042 (Figure 1, left) indicates that EAD preferentially breaks the ester bond between the O and the C=O of the ester bond, whereas CID favors breaking the bond between the C and O adjacent to the ester bond. The intense peak at m/z 172.1725 (Figure 1, left) shows fragmentation of the head group of the molecule, which was not observed by CID. This fragment was important to identify the oxidation site in ALC-0315 impurities.
The peak at m/z 782.7271 (Figure 3, peak 2) was the primary impurity of ALC-0315 and occurred with 5.9% relative intensity. The m/z of this impurity was 15.9943 Da more than that of intact ALC-0315 (m/z = 766.7274), indicating that O was incorporated.
The intensity of this peak increased with the forced degradation timecourse (Figure 2, right). Figure 4 shows the EAD fragmentation spectra for ALC-0315 and the unknown oxidation product. The peak at m/z 544.4956 (Figure 4, bottom) from oxidized ALC-0315 is 15.9914 Da more than the m/z 528.5042 (Figure 4, top) fragment from intact ALC-0315. This observation indicates that O was incorporated to the left of the ester bond. Similarly, the peak at m/z 443.3988 (Figure 4, bottom) from the oxidized ALC-0315 is 15.9917 Da more than the peak at m/z 427.4071(Figure 4, top) from the intact ALC-0315, which indicates the addition of that O was added to the left of the C-N bond. Finally, the addition of 14.9854 Da (187.1579 (Figure 4, bottom)-172.1725 (Figure 4, top) = 14.9854) corresponds to the gain of one O and loss of H on the head group N atom.
Figure 4. MS/MS spectra acquired for ALC-0315 (m/z = 766.7) and its oxidized impurity (m/z = 782.7) using EAD. Blue peaks were assigned to a fragment of the structure. Red peaks were not assigned. More than 70% of the EAD-based fragment peaks were assigned for both spectra.
Figure 5 shows the CID spectra generated for ALC-0315 (top panel) and the oxidized impurity (bottom panel). The 16 Da difference between peaks at m/z 438 and 454 and peaks at m/z 694 and 710 indicates O incorporation in the oxidized ALC-0315 to the left of the ester bond. However, the diagnostic fragments containing the head group were not observed in the CID spectra to further localize the oxidation. Only EAD-based fragmentation generated the diagnostic fragments necessary for such confident structural elucidation.
Figure 5. CID-based MS/MS spectra acquired from ALC-0315 (top panel, m/z = 766.7) and its oxidized impurities (bottom panel, m/z = 782.7). Blue peaks were assigned to a fragment of the structure. Red peaks were not assigned. The lack of head group fragments prevented the localization of O incorporation. The CID data indicate that the O incorporation can be anywhere to the left of the ester bond.
EAD spectra were also used to characterize the peak at m/z 780.7061 that eluted at 10.77 min (Figure 3, peak 7). The intensity of this peak increased over the 5-day forced degradation timecourse (data not shown) and was present at 0.19% relative intensity in ALC-0315-5D sample (Table 4). Despite the relatively low abundance of this impurity peak, an information-rich EAD spectrum was successfully acquired. The intact mass of 780.7061 Da corresponds to the gain O and loss of 2 H from intact ALC-0315. Two structures are possible with this specific mass addition: 1) oxidation at the head group N and double bond formation on the alkyl chain and 2) oxidation of the hydroxyl moiety to yield a carboxylic acid. Figure 6 shows the MS/MS spectra acquired via EAD (top panel) and CID (bottom panel). The EAD spectrum confirms that the peak at m/z 780.7061 corresponds to oxidation of the hydroxyl functional group. The peak at m/z 542.4767 designates the gain of O and loss of 2 H to the left of the ester bond and the fragment at m/z 438.4278 indicates that no O is present on the N of the head group. Combined with the peak at m/z 186.1488, these data indicate that O is incorporated at and the 2 H are lost from the head group, resulting in the oxidation of the hydroxyl moiety to a carboxylic acid functional group. In contrast, the CID data (Figure 6, bottom panel) were insufficient to distinguish between the 2 possible structures.
Figure 6. MS/MS spectra acquired for the hydroxyl-to-carboxyl impurity using EAD (top panel) and CID (bottom panel) (m/z = 780.7). Blue peaks were assigned to a fragment of the structure. Red peaks were not assigned. EAD generated a fragment containing the head group, indicating the oxidation of the hydroxyl moiety to a carboxylic acid functional group.
The data generated by EAD provided better descriptions of important structural features than the same experimental data acquired using CID. CID yielded low fragmentation efficiency and most fragment ions had less than 5% relative intensity compared to the parent ion. This workflow leveraged the speed, sensitivity and broad dynamic range of the ZenoTOF 7600 system. The unique hardware configuration of the ZenoTOF 7600 system made it well-suited for the analysis and quality control of LNP formulations and their individual components. Data generated using this workflow can be used to determine the efficacy and safety of formulated LNPs and to aid the rational design of new synthetic lipids.